Skip To Main Content
Jieying Yang on Muck Rack

Jieying Yang

As seen in: Nature, Wiley Online Library, Frontiers, Journal of Biomedical Science
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jieying

Contact Jieying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Annexin A3 potentiates lenvatinib resistance in hepatocellular carcinoma through multiple approaches amplified by a positive feedback loop

|
By Yingqin Zhu, Yue Huang, Mengjia Song, Jieying Yang, Jingjing Zhao, Yan Tang, Dijun Ouyang, Chaopin Yang, Yuanyuan Chen, Qijing Wang, Yongqiang Li, Jia He, Hao Chen, Tong Xiang, Jianchuan Xia, Qiuzhong Pan
| Nature Verified
Abstract Hepatocellular carcinoma (HCC) is one of the most lethal malignancies with limited treatment options. Lenvatinib is a first-line drug for advanced HCC. However, its effect on patient survival is limited and patients ultimately develop disease progression due to drug resistance. In this study, we established a lenvatinib-resistant orthotopic xenograft model and found a significant upregulation of ANXA3.
Open in Who Shared Issue with article?

Construction of Axially Chiral Dialdehydes via Rhodium‐Catalyzed Enantioselective C−H Amidation

|
By Jieying Yang, Yaru Du, Fuqiang Cheng, Kun An
| Wiley Online Library Verified
Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Open in Who Shared View Duplicates (700) Issue with article?

Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRβ complex in hepatocellular carcinoma

|
By Guangzhou Laboratory, Jieying Yang, Yang Zhao, Suyun Yu
| Frontiers
1Department of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, China 2Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China 3Department of Ultrasound, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China 4Department of Oncology and Translational Medicine Center, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China 5Guangzhou Laboratory,...
Open in Who Shared Issue with article?
See all 6 articles